课题基金 / 基金详情

EFFECT OF COMPLEMENTARY DRUG REGIMEN ON CORONARY ARTERIOSCLEROSIS

EFFECT OF COMPLEMENTARY DRUG REGIMEN ON CORONARY ARTERIOSCLEROSIS
补充药物疗法对冠状动脉硬化的影响
批准号:
3741087
负责人:
JOHN P KANE
金额:
$0.0万
依托单位国家:
美国
项目类别:
财政年份:
--
资助国家:
美国
项目状态:
未结题
起止时间:

项目摘要

项目成果

JOHN P KANE的其他基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
These studies are a continuation of protocol #20-1, except for the addition of probucol as one of the drugs. Since we can now normalize LDL cholesterol in patients with heterozygous familial hypercholesterolemia using a combined drug regimen, we are testing the regimen's ability to shrink atherosclerotic plaques as measured by computerized angiography. Patients are studied in the GCRC for the effect of treatment on levels of plasma free fatty acid.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
ANALYSIS OF THE PROTEIN COMPOSITION OF ARTERIOSCLEROTIC PLAQUES
COMPOSITION OF HIGH DENSITY LIPOPROTEIN SUBCLASSES
COMPOSITION OF HIGH DENSITY LIPOPROTEIN SUBCLASSES
COMPOSITION OF HIGH DENSITY LIPOPROTEIN SUBCLASSES